Clinical Trial

A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is a multicenter study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of treatment with SNH-119014 in adult participants with non-transfusion-dependent thalassemia. 30 participants with non-transfusion-dependent thalassemia were enrolled.
Trial Details
NCT Number NCT07579949
Lead Sponsor ScinnoHub Pharmaceutical Co., Ltd.
Conditions Thalassemia
Enrollment 30 participants
Start Date 2026-06-18
Primary Completion 2027-03-29 (estimated)
Study Completion 2027-04-29 (estimated)
Updated on ClinicalTrials.gov 2026-05-12